Symptomatic improvement with one-year cisapride treatment in neuropathic chronic intestinal dysmotility

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 3, 1996, Pages 403-409

  Camilleri, M ^a   Balm, R K ^a   Zinsmeister, A R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTESTINE MOTILITY; MALE; NEUROPATHY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANTI-ULCER AGENTS; AUTONOMIC NERVOUS SYSTEM DISEASES; CHRONIC DISEASE; CISAPRIDE; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL DISEASES; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PIPERIDINES; REGRESSION ANALYSIS;

EID: 0030011445     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0953-0673.1996.00403.x     Document Type: Article

References (14)

1. Camilleri M. Appraisal of medium- and long-term treatment of gastroparesis and chronic intestinal dysmotility. Am J Gastroenterol 1994; 89: 1769-74.
2. Abell TL, Camilleri M, DiMagno EP, et al. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci 1991; 36: 616-20.
3. Camilleri M, Balm RK, Zinsmeister AR. Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder. Gastroenterology 1994; 106: 916-23.
4. Camilleri M. Disorders of gastrointestinal motility in neurologic diseases. Mayo Clin Proc 1990; 65: 825-46.
5. Greydanus MP, Vassallo M, Camilleri M, et al. Neurohormonal factors in functional dyspepsia: insights on pathophysiologic mechanisms. Gastroenterology 1991; 100: 1311-8.
6. Stanghellini V, Camilleri M, Malagelada J-R. Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut 1987; 28: 5-12.
7. Greydanus MP, Camilleri M, Colemont LJ, et al. Ileocolonic transfer of solid chyme in small intestinal neuropathies and myopathies. Gastroenterology 1990; 99: 158-64.
8. Koch KL, Stern RM, Stewart WR, et al. Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of long-term domperidone treatment. Am J Gastroenterol 1989; 84: 1069-75.
9. Richards RD, Davenport K, McCallum RW. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol 1993; 88: 203-7.
10. Rothstein RD, Alavi A, Reynolds JC. Electrogastrography in patients with gastroparesis and effect of long-term cisapride. Dig Dis Sci 1993; 38: 1518-24.
11. Hyman PE, Di Lorenzo C, McAdams L, et al. Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction. Am J Gastroenterol 1995; 88: 832-6
12. Messing B, Lémann M, Landais P, et al. Prognosis of patients with nonmalignant chronic intestinal failure receiving long-term home parenteral nutrition. Gastroenterology 1995; 108: 1005-10.
13. Di Lorenzo C, Flores AP, Buie T, Hyman PE. Intestinal motility and jejunal feeding in children with chronic intestinal pseudo-obstruction. Gastroenterology 1995; 108: 1379-85.
14. Fontana RJ, Barnett JL. Severe refractory diabetic gastroparesis. What is the utility of jejunostomy tube placement? A long-term retrospective review of 26 patients. Gastroenterology 1995; 108: A599.